Investigating Voice as a Biomarker for leucine-rich repeat kinase 2-Associated Parkinson's Disease

Authors: S. Arora, N. P. Visanji, T. A. Mestre, A. Tsanas, A. AlDakheel, B. S. Connolly, C. Gasca-Salas, D. S. Kern, J. Jain, E. J. Slow, A. Faust-Socher, A. E. Lang, M. A. Little, C. Marras

27 pages including supplemental information, Journal of Parkinson's Disease, 2018

Abstract: We investigate the potential association between leucine-rich repeat kinase 2 (LRRK2) mutations and voice. Sustained phonations ('aaah' sounds) were recorded from 7 individuals with LRRK2-associated Parkinson's disease (PD), 17 participants with idiopathic PD (iPD), 20 non-manifesting LRRK2-mutation carriers, 25 related non-carriers, and 26 controls. In distinguishing LRRK2-associated PD and iPD, the mean sensitivity was 95.4% (SD 17.8%) and mean specificity was 89.6% (SD 26.5%). Voice features for non-manifesting carriers, related non-carriers, and controls were much less discriminatory. Vocal deficits in LRRK2-associated PD may be different than those in iPD. These preliminary results warrant longitudinal analyses and replication in larger cohorts

Submitted to arXiv on 20 Oct. 2018

Explore the paper tree

Click on the tree nodes to be redirected to a given paper and access their summaries and virtual assistant

Also access our AI generated Summaries, or ask questions about this paper to our AI assistant.

Beta

Look for similar papers (in beta version)

We compare the title and abstract with papers indexed in our database. For arXiv papers, we search within the same category; for DOI and other sources, we search across sources and subjects. You can rerun the search as our database grows.